-
July 16, 2019PREVIEW
A trial published in the American Journal of Psychiatry suggests that adding esketamine (Spravato—Janssen) to an antidepressant for those with treatment-resistant depression (TRD) is more...
-
April 23, 2019PREVIEW
Duloxetine, pregabalin (Lyrica—Pfizer), venlafaxine, and escitalopram may be the preferred treatment options for generalized anxiety disorder (GAD) based on their efficacy and safety profiles,...
-
January 28, 2019PREVIEW
Children and young adults aged 5 years to 24 years who were prescribed higher doses of antipsychotics were found to be at a 1.8-times higher risk of death from any cause, 3.5-times higher risk of...
-
December 18, 2018PREVIEW
I.V. boluses of haloperidol or ziprasidone were not effective for management of patients with hypoactive or hyperactive delirium in the ICU compared with placebo, according to results of a trial...
-
December 11, 2018PREVIEW
High-volume primary care prescribers of quetiapine who received letters stating their use of the drug was higher than their peers and was under review by Medicare resulted in less prescribing of...
Pages
